ME01000B - Živa vakcina avirulentne mycoplasma hyopneumoniae sa adjuvansom - Google Patents

Živa vakcina avirulentne mycoplasma hyopneumoniae sa adjuvansom

Info

Publication number
ME01000B
ME01000B MEP-2010-78A MEP7810A ME01000B ME 01000 B ME01000 B ME 01000B ME P7810 A MEP7810 A ME P7810A ME 01000 B ME01000 B ME 01000B
Authority
ME
Montenegro
Prior art keywords
hyopneumoniae
adjuvant
avirulent
compositions
compositions containing
Prior art date
Application number
MEP-2010-78A
Other languages
English (en)
Inventor
Nicole Rae Gibson
Hsien-Jue Chu
Zhichang Xu
Wumin Li
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of ME01000B publication Critical patent/ME01000B/me

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Dati su imunogeni sastavi, vakcine i metodi za njihovo dobijanje i upotrebu. Ovi sastavi su efkasni u zaštiti od M   hyopneumoniae,   minimizovanju   žestin e , sprečavanju  i/ili ublažavanju infekcije M hyopneumoniom. Davanje životinji jedne ili dve doze ovde opisanih sastava sa živom avirulentnom M    hyopneumoniae   i    adjuvansom   efikasno   je   u   stvaranju   imuniteta   kod   životinje   i   zaštite   od infekcije virulentnim sojem M   hyopneumoniae, čime se smanjuje ozbiljnost i/ili sprečava oboljenje izazvano jednim ili više virulentnih sojeva M   hyopneumoniae . Dati su takođe sastavi koji sadrže još jedan ili više antigena kao što s u , na prime r , jedna ili više bakterij a ,   bakterin a , toksoid a , i / ili virusa i/ili virusnih antigena. Dati su primeri imunogenih sastava koji sadrže živu avirulentnu M hyopneumoniae sa adjuvansom i sastavi koji sadrže modifikovanu živu vakcinu himere svinjskog Circovirusa   Tip   l-Tip   2 (cPCVl-2) u kombinaciji   sa živom  avirulentnom   M   hyopneumoniae   i adjuvansom.
MEP-2010-78A 2007-11-06 2008-11-05 Živa vakcina avirulentne mycoplasma hyopneumoniae sa adjuvansom ME01000B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98581107P 2007-11-06 2007-11-06
PCT/US2008/082454 WO2009061798A1 (en) 2007-11-06 2008-11-05 Mycoplasma hyopneumoniae avirulent -adjuvanted live vaccine

Publications (1)

Publication Number Publication Date
ME01000B true ME01000B (me) 2012-10-20

Family

ID=40303616

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2010-78A ME01000B (me) 2007-11-06 2008-11-05 Živa vakcina avirulentne mycoplasma hyopneumoniae sa adjuvansom

Country Status (20)

Country Link
US (1) US9056909B2 (me)
EP (1) EP2217271B1 (me)
JP (1) JP5869221B2 (me)
KR (1) KR101225304B1 (me)
CN (2) CN104043116A (me)
AR (1) AR069216A1 (me)
AU (1) AU2008324780A1 (me)
BR (1) BRPI0820341B1 (me)
CA (1) CA2704775C (me)
CL (1) CL2008003304A1 (me)
CO (1) CO6270337A2 (me)
DK (1) DK2217271T3 (me)
HK (1) HK1198289A1 (me)
ME (1) ME01000B (me)
MX (1) MX2010005014A (me)
RU (1) RU2489164C9 (me)
TW (1) TWI513463B (me)
UA (1) UA98812C2 (me)
WO (1) WO2009061798A1 (me)
ZA (1) ZA201004026B (me)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
AU2010251761B2 (en) * 2009-05-19 2014-10-09 Bioproperties Pty Ltd A temperature sensitive vaccine strain of Mycoplasma hyopneumoniae and uses thereof
CA2799732A1 (en) * 2010-05-19 2011-11-24 Bioproperties Pty Ltd Methods relating to an attenuated mycoplasma
CN105327344B (zh) * 2011-08-01 2019-03-05 普莱柯生物工程股份有限公司 含有猪圆环病毒2型抗原与副猪嗜血杆菌抗原的疫苗组合物及其制备方法与应用
CN103083658B (zh) * 2011-10-27 2015-09-02 普莱柯生物工程股份有限公司 一种用于治疗或预防猪感染性疾病的疫苗佐剂组合物
CN103157100B (zh) * 2011-12-08 2014-09-24 普莱柯生物工程股份有限公司 副猪嗜血杆菌病、猪链球菌病二联灭活疫苗及其制备方法
CN103157104B (zh) * 2011-12-14 2015-11-18 普莱柯生物工程股份有限公司 猪瘟疫苗的硫代硫酸钠稀释液
MX362166B (es) 2012-03-07 2018-12-14 Ceva Sante Animale Nueva vacuna veterinaria.
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
EP2684959A1 (en) * 2012-07-10 2014-01-15 Laboratorios Hipra, S.A. Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
CN104685057B (zh) * 2012-07-10 2019-04-16 海博莱科学有限公司 用于转化猪肺炎支原体的载体，转化的猪肺炎支原体菌株及其用途
CN103623400B (zh) * 2012-08-24 2016-08-17 普莱柯生物工程股份有限公司 抗猪支原体肺炎、传染性胸膜肺炎疫苗组合物及制备方法
CN103861095B (zh) * 2012-12-11 2016-03-09 普莱柯生物工程股份有限公司 含猪支原体肺炎抗原和猪链球菌病抗原的疫苗组合物及其制备方法和应用
SG10201708028VA (en) * 2012-12-28 2017-10-30 Boehringer Ingelheim Vetmedica Gmbh Method of making a mycoplasma vaccine
CN104981252B (zh) 2012-12-28 2019-06-18 勃林格殷格翰动物保健有限公司 包含支原体抗原的免疫原性组合物
EP2994162B1 (en) 2013-05-08 2021-04-07 Pharmgate Biologics Inc. Vaccine for pcv2 and mycoplasma
CN104338128B (zh) * 2013-07-31 2017-09-05 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
US20160199482A1 (en) * 2013-09-05 2016-07-14 Zoetis Services Llc Hendra and nipah virus g glycoprotein immunogenic compositions
CN104248759B (zh) * 2013-11-19 2017-05-10 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
US10279031B2 (en) * 2016-05-11 2019-05-07 Phibro Animal Health Corporation Composition comprising antigens and a mucosal adjuvant and a method for using
EP3498847A4 (en) * 2016-08-12 2020-03-04 Innovac VACCINE COMPOSITION FOR PREVENTING SWINE MYCOPLASM INFECTION COMPRISING A RECOMBINANT PROTEIN
CN109234418B (zh) * 2018-11-20 2021-08-13 湖南中净生物科技有限公司 一种鉴别猪肺炎支原体野毒株和疫苗株的引物、试剂盒和方法
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN112143666B (zh) * 2020-09-07 2023-02-21 华中农业大学 一种猪肺炎支原体弱毒株及其在制备弱毒疫苗中的应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917619A (en) 1972-03-06 1975-11-04 Bayer Ag 2-Amino-4,5-dihydropyridine derivatives
JPS5540568B2 (me) * 1972-10-05 1980-10-18
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
FR2565825B1 (fr) 1984-06-15 1990-07-13 Centre Nat Rech Scient Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
JPS62273456A (ja) 1986-05-21 1987-11-27 Tosoh Corp 分析装置用に用いるテストカツプのシ−ル箔破開用シ−ルブレ−カ
JPH0795069B2 (ja) * 1986-05-22 1995-10-11 農林水産省家畜衛生試験場長 マウスＩｇＡ単クローン抗体を用いる豚マイコプラズマ肺炎の診断方法
EP0283840A3 (en) 1987-03-26 1989-08-09 Ml Technology Ventures, L.P. Mycoplasma hyopneumoniae antigen and uses therefor
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP0571648A1 (en) 1992-05-26 1993-12-01 Chung-Nan Weng Vaccine protecting against mycoplasmal pneumonia
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
ZA9710606B (en) * 1996-12-05 1998-06-12 Akzo Nobel Nv Non-virulent Mycoplasma synoviae vaccine thereof.
IL149471A0 (en) * 1999-11-08 2002-11-10 Biomune Vaccines for mycoplasma bovis and methods for immunizing bovine amimals
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
EP1521592A2 (en) * 2001-07-02 2005-04-13 Pfizer Products Inc. Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
KR20040030785A (ko) * 2001-07-02 2004-04-09 화이자 프로덕츠 인크. 마이코플라즈마 하이오뉴모니애로의 1회 투여량 예방접종
PL212212B1 (pl) * 2001-07-27 2012-08-31 Wyeth Corp Kompozycja szczepionki przeciwko zakażeniu wirusem Zachodniego Nilu, kompozycja końskiej szczepionki, szczepionka wirusa Zachodniego Nilu oraz zastosowania
US20030129161A1 (en) 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
BR0309008A (pt) 2002-04-05 2007-01-30 Univ Iowa State Res Found Inc polipeptìdeos de micoplasma
TWI350174B (en) 2003-03-12 2011-10-11 Wyeth Corp Adjuvanted bovine vaccines
RU2278704C2 (ru) * 2004-01-12 2006-06-27 Алексей Борисович Башкиров Метод индукции иммунного ответа организма млекопитающих-2

Also Published As

Publication number Publication date
US20090117152A1 (en) 2009-05-07
RU2489164C9 (ru) 2014-01-20
BRPI0820341A2 (pt) 2020-05-19
ZA201004026B (en) 2011-04-28
TW200927166A (en) 2009-07-01
RU2010117614A (ru) 2011-12-20
UA98812C2 (ru) 2012-06-25
KR101225304B1 (ko) 2013-01-22
CN101883581A (zh) 2010-11-10
EP2217271A1 (en) 2010-08-18
CO6270337A2 (es) 2011-04-20
MX2010005014A (es) 2010-06-30
BRPI0820341B1 (pt) 2021-11-09
US9056909B2 (en) 2015-06-16
TWI513463B (zh) 2015-12-21
AR069216A1 (es) 2010-01-06
CA2704775A1 (en) 2009-05-14
EP2217271B1 (en) 2016-05-04
CA2704775C (en) 2016-05-10
RU2489164C2 (ru) 2013-08-10
DK2217271T3 (en) 2016-06-06
CL2008003304A1 (es) 2009-01-09
JP2011503086A (ja) 2011-01-27
JP5869221B2 (ja) 2016-02-24
WO2009061798A1 (en) 2009-05-14
CN104043116A (zh) 2014-09-17
KR20100087202A (ko) 2010-08-03
HK1198289A1 (en) 2015-03-27
AU2008324780A1 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
ME01000B (me) Živa vakcina avirulentne mycoplasma hyopneumoniae sa adjuvansom
NZ591950A (en) Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
AR041880A1 (es) Composicion inmunogena
AR052625A1 (es) Nueva composicion
MX2010007815A (es) Composiciones inmunogenicas de mycoplasma hyopneumoniae contra pcv2 y metodos para producir composiciones de este tipo.
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
MX2009006178A (es) Vacuna contra salmonela.
BR112015005056A2 (pt) vacinas de combinação com sorogrupo b meningococcus e d/t/p
NZ595914A (en) Vaccines comprising attenuated mycoplasma bovis strains and method for the attenuation
PE20140646A1 (es) Vacuna de virus de dengue inactivado
BR112013017171A2 (pt) vacina de combinação imunogênica estável, processo de preparação de vacina de combinação estável, método de uso de moléculas antigênicas e método de administração a indivíduos humanos
PH12021550479A1 (en) Dengue vaccine unit dose and administration thereof
BR112012021650A2 (pt) "parvovírus recombinante atenuado, vacina para a proteção de animais contra infecção com parvovírus, método para a obtenção de um parvovírus recombinante, e, uso de uma vacina."
CO6280408A2 (es) Vacuna de virus de la lengua azul y composiciones inmunogenicas procedimientos de uso y procedimeintos de la produccuion de la misma
UY31437A1 (es) Vacuna de mycoplasma bovis y métodos de uso de la misma
MX2018007950A (es) Vacuna multivalente m hyo y usos de la misma.
CL2008003845A1 (es) Vacuna que comprende una emulsion, una bacterina tratada termicamente a 55-70°c por 5-10 horas, que comprende una suspension de bacterias muertas de la especie leptospira bratislava, y de 1 a 13 virus causantes de enfermedad porcina.
MY153290A (en) Multivalent avian influenza vaccines
NO20090290L (no) Polyvalent vaksine mot salmonid alfavirusinfeksjoner
RS53607B1 (en) HPV vaccine
DK3076997T3 (en) SVINEVACCINE v PRRS AND LAWSONIA INTRACELLULARIS
BR112016025977A2 (pt) composições, métodos e utilizações para formulações de papilomavirus humano estábulo estável
CL2023002187A1 (es) Virus para vacuna contra el síndrome respiratorio y reproductivo porcino
AR093424A1 (es) Vacunas atenuadas de mannheimia haemolytica y metodos para su elaboracion y uso
MX2022003090A (es) Vacuna combinada para ser administrable intradermicamente.